Fusion Pharmaceuticals Inc (FUSN)
21.41
+0.01
(+0.05%)
USD |
NASDAQ |
May 09, 15:32
Fusion Pharmaceuticals 1 Year Total Returns (Daily): 393.1% for May 8, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| May 08, 2024 | 393.1% |
| May 07, 2024 | 409.5% |
| May 06, 2024 | 410.0% |
| May 03, 2024 | 424.4% |
| May 02, 2024 | 467.0% |
| May 01, 2024 | 422.4% |
| April 30, 2024 | 456.6% |
| April 29, 2024 | 455.8% |
| April 26, 2024 | 474.3% |
| April 25, 2024 | 478.4% |
| April 24, 2024 | 461.7% |
| April 23, 2024 | 468.2% |
| April 22, 2024 | 465.5% |
| April 19, 2024 | 458.0% |
| April 18, 2024 | 418.3% |
| April 17, 2024 | 406.9% |
| April 16, 2024 | 423.6% |
| April 15, 2024 | 424.1% |
| April 12, 2024 | 411.0% |
| April 11, 2024 | 435.3% |
| April 10, 2024 | 456.2% |
| April 09, 2024 | 477.8% |
| April 08, 2024 | 478.4% |
| April 05, 2024 | 445.3% |
| April 04, 2024 | 462.5% |
| Date | Value |
|---|---|
| April 03, 2024 | 461.6% |
| April 02, 2024 | 464.7% |
| April 01, 2024 | 463.7% |
| March 28, 2024 | 458.1% |
| March 27, 2024 | 432.5% |
| March 26, 2024 | 432.5% |
| March 25, 2024 | 429.5% |
| March 22, 2024 | 414.3% |
| March 21, 2024 | 427.4% |
| March 20, 2024 | 427.2% |
| March 19, 2024 | 410.4% |
| March 18, 2024 | 156.4% |
| March 15, 2024 | 137.9% |
| March 14, 2024 | 119.8% |
| March 13, 2024 | 131.1% |
| March 12, 2024 | 133.5% |
| March 11, 2024 | 132.0% |
| March 08, 2024 | 129.7% |
| March 07, 2024 | 120.9% |
| March 06, 2024 | 113.8% |
| March 05, 2024 | 119.2% |
| March 04, 2024 | 125.3% |
| March 01, 2024 | 171.3% |
| February 29, 2024 | 170.6% |
| February 28, 2024 | 176.0% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-76.62%
Minimum
Aug 30 2022
478.4%
Maximum
Apr 08 2024
15.99%
Average
-36.17%
Median
Apr 26 2022
1 Year Total Returns (Daily) Benchmarks
| AstraZeneca PLC | 4.43% |
| Landos Biopharma Inc | 693.0% |
| Perspective Therapeutics Inc | 163.1% |
| Acasti Pharma Inc | 4.71% |
| Aurinia Pharmaceuticals Inc | -53.98% |